1PCG
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions
Functional Information from PDB Data
| site_id | AC1 |
| Number of Residues | 7 |
| Details | BINDING SITE FOR RESIDUE EST A 1 |
| Chain | Residue |
| A | LEU346 |
| A | GLU353 |
| A | LEU387 |
| A | ARG394 |
| A | PHE404 |
| A | HIS524 |
| A | LEU525 |
| site_id | AC2 |
| Number of Residues | 7 |
| Details | BINDING SITE FOR RESIDUE EST B 2 |
| Chain | Residue |
| B | LEU391 |
| B | ARG394 |
| B | PHE404 |
| B | HIS524 |
| B | LEU525 |
| B | GLU353 |
| B | LEU387 |
| site_id | AC3 |
| Number of Residues | 10 |
| Details | BINDING SITE FOR CHAIN E OF PEPTIDE INHIBITOR |
| Chain | Residue |
| A | ASP313 |
| A | SER317 |
| A | LEU320 |
| A | ILE358 |
| A | LYS362 |
| A | LEU372 |
| A | VAL376 |
| A | GLU380 |
| A | GLY442 |
| A | GLU542 |
| site_id | AC4 |
| Number of Residues | 10 |
| Details | BINDING SITE FOR CHAIN F OF PEPTIDE INHIBITOR |
| Chain | Residue |
| B | ILE358 |
| B | LYS362 |
| B | THR371 |
| B | LEU372 |
| B | LEU372 |
| B | VAL376 |
| B | ASP538 |
| B | LEU539 |
| B | GLU542 |
| B | MET543 |
Functional Information from SwissProt/UniProt
| site_id | SWS_FT_FI1 |
| Number of Residues | 6 |
| Details | Binding site: {"evidences":[{"source":"PubMed","id":"9338790","evidenceCode":"ECO:0000269"},{"source":"PubMed","id":"9600906","evidenceCode":"ECO:0000269"},{"source":"PDB","id":"1A52","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"1ERE","evidenceCode":"ECO:0007744"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI2 |
| Number of Residues | 2 |
| Details | Modified residue: {"description":"Phosphotyrosine; by Tyr-kinases","evidences":[{"source":"PubMed","id":"7539106","evidenceCode":"ECO:0000269"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI3 |
| Number of Residues | 2 |
| Details | Lipidation: {"description":"S-palmitoyl cysteine","evidences":[{"evidenceCode":"ECO:0000250"}]} |
| Chain | Residue | Details |
